CA
NZ
UK
AU
IND
US
• AC Immune has drawn increased market attention after a share-price decline that coincides with wavering sentiment across the biotech space.
• AMASS Brands has drawn heightened market attention after a share-price drop that adds a fresh test for the consumer-focused name.
• The company announced two fronting carrier partnerships covering more than $500 million in annual gross written premiums.
• Fiscal 2026 revenue reached $5.37 million, up 28.5% from $4.18 million in fiscal 2025.
• A price target upgrade lifted the consensus estimate from $37.50 to $42.50, a 13% increase.
• First-quarter 2026 revenue reached $1.42 billion, topping estimates, with earnings per share of $2.94 against consensus of $0.93.
• The stock benefited from a broader sector rotation into healthcare and medical technology names.
• NeuroOne Medical Technology has drawn fresh market attention following a notable share-price decline that has weighed on investor sentiment.
Metallus Inc. (NYSE: MTUS) announced on June 30 2026 that it has executed a Fifth Amended and Restated Credit Agreement, establishing a $300 million asset‑based revolving credit facility. The agreement, administered by JPMorgan Chase Bank, N.A. Is secured by the Company’s assets and those …
McEwen Inc. (NYSE: MUX), a company active in the mining sector, has recently reported notable stock transactions involving its leadership team. These developments occur as the company navigates a complex landscape marked by fluctuating commodity prices and operational challenges.
Please wait processing your request...